GPES COVID-19 At Risk Patients data collection version 5

At the request of the Deputy Chief Medical Officer (DCMO), an advisory group, supported by the NHS England RAPID-C19 team, was constituted to identify a set of patient conditions (or cohorts) that were deemed to be at the very highest risk of an adverse COVID-19 outcome, namely hospitalisation and death. The recommendations are to support the deployment of approved medications for treatment or prophylaxis, potentially across a range of scenarios, but the group was tasked to focus on those in the community with clinically proven COVID-19.

The advisory group sought to generate a list of conditions or cohorts of greatest risk of adverse outcome following COVID-19.


Our approach is described in detail following this link


https://www.gov.uk/government/publications/higher-risk-patients-eligible-for-covid-19-treatments-independent-advisory-group-report/defining-the-highest-risk-clinical-subgroups-upon-community-infection-with-sars-cov-2-when-considering-the-use-of-neutralising-monoclonal-antibodies